{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:54:07Z","timestamp":1778932447555,"version":"3.51.4"},"reference-count":52,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A650372"],"award-info":[{"award-number":["N42A650372"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["D003276"],"award-info":[{"award-number":["D003276"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mahidol University","award":["N42A650372"],"award-info":[{"award-number":["N42A650372"]}]},{"name":"Mahidol University","award":["D003276"],"award-info":[{"award-number":["D003276"]}]},{"name":"Siriraj Foundation for Stem Cell Research","award":["N42A650372"],"award-info":[{"award-number":["N42A650372"]}]},{"name":"Siriraj Foundation for Stem Cell Research","award":["D003276"],"award-info":[{"award-number":["D003276"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin lymphoma with poor prognosis, due to the inevitable development of drug resistance. Despite being the first-in-class proteasome inhibitor for relapsed\/refractory MCL, resistance to bortezomib (BTZ) in MCL patients remains a major hurdle of effective therapy, and relapse following BTZ is frequent. Understanding the mechanisms underlying BTZ resistance is, therefore, important for improving the clinical outcome and developing novel therapeutic strategies. Here, we established de novo BTZ-resistant human MCL-derived cells with the highest resistance index of 300-fold compared to parental cells. We provided compelling evidence that both Bcl-xL and Bax are key mediators in determining BTZ sensitivity in MCL cells. Overexpression of antiapoptotic Bcl-xL and depletion of proapoptotic Bax cooperatively protected MCL cells against BTZ-induced apoptosis, causing acquired BTZ resistance, likely by tilting the balance of Bcl-2 family proteins toward antiapoptotic signaling. Bioinformatics analyses suggested that high BCL2L1 (encoded Bcl-xL) and low BAX were, in part, associated with poor prognosis of MCL patients, e.g., when combined with low OGT, which regulates cellular O-GlcNAcylation. Our findings support recent strategies in small molecule drug discovery co-targeting antiapoptotic Bcl-2 family proteins using BH3 mimetics and Bax using Bax activators to overcome cancer drug resistance.<\/jats:p>","DOI":"10.3390\/ijms232214474","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T02:59:22Z","timestamp":1669085962000},"page":"14474","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-4935","authenticated-orcid":false,"given":"Sudjit","family":"Luanpitpong","sequence":"first","affiliation":[{"name":"Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montira","family":"Janan","sequence":"additional","affiliation":[{"name":"Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juthamas","family":"Yosudjai","sequence":"additional","affiliation":[{"name":"Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jirarat","family":"Poohadsuan","sequence":"additional","affiliation":[{"name":"Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pithi","family":"Chanvorachote","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand"},{"name":"Cell-Based Drug and Health Product Development Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapol","family":"Issaragrisil","sequence":"additional","affiliation":[{"name":"Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"},{"name":"Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand"},{"name":"Bangkok Hematology Center, Wattanosoth Hospital, BDMS Center of Excellence for Cancer, Bangkok 10310, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am. J. Hematol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24797","article-title":"Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management","volume":"92","author":"Vose","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1158\/1078-0432.CCR-07-0871","article-title":"Bortezomib for the treatment of mantle cell lymphoma","volume":"13","author":"Kane","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdn656","article-title":"Bortezomib in patients with relapsed or refractory mantle cell lymphoma: Updated time-to-event analyses of the multicenter phase 2 PINNACLE study","volume":"20","author":"Goy","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2141.2008.07466.x","article-title":"Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: Results of a multicentre Phase 2 clinical trial","volume":"145","author":"Moskowitz","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: Biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"Dreyling","year":"2011","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/CCO.0b013e32833d58f2","article-title":"Mantle cell lymphoma in relapse: The role of emerging new drugs","volume":"22","author":"Diefenbach","year":"2010","journal-title":"Curr. Opin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/1535-7163.363.3.3","article-title":"Cytochrome P450 enzymes: Novel options for cancer therapeutics","volume":"3","author":"McFadyen","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/sj.onc.1207515","article-title":"Apoptosis defects and chemotherapy resistance: Molecular interaction maps and networks","volume":"23","author":"Pommier","year":"2004","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","author":"Weniger","year":"2011","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"38225","DOI":"10.18632\/oncotarget.5425","article-title":"Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Luanpitpong, S., Janan, M., Thumanu, K., Poohadsuan, J., Rodboon, N., Klaihmon, P., and Issaragrisil, S. (2019). Deciphering the elevated lipid via CD36 in mantle cell lymphoma with bortezomib resistance using synchrotron-based Fourier transform infrared spectroscopy of single cells. Cancers, 11.","DOI":"10.3390\/cancers11040576"},{"key":"ref_15","first-page":"2168","article-title":"Cell cycle-mediated drug resistance: An emerging concept in cancer therapy","volume":"7","author":"Shah","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2016-05-718775","article-title":"B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma","volume":"129","author":"Dai","year":"2017","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1038\/onc.2012.543","article-title":"STK38 is a critical upstream regulator of MYC\u2019s oncogenic activity in human B-cell lymphoma","volume":"32","author":"Bisikirska","year":"2013","journal-title":"Oncogene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3324\/haematol.2010.031567","article-title":"Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinasein mantle cell lymphoma","volume":"96","author":"Vishwamitra","year":"2011","journal-title":"Haematologica"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood-2010-05-284075","article-title":"Discovery of Hippo in MCL","volume":"116","author":"Auer","year":"2010","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-015-0161-1","article-title":"Targeting Wnt pathway in mantle cell lymphoma-initiating cells","volume":"8","author":"Mathur","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2003-4-9-r60","article-title":"DAVID: Database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-61779-439-1_3","article-title":"Interleukin-27 induces interferon-inducible genes: Analysis of gene expression profiles using Affymetrix microarray and DAVID","volume":"820","author":"Imamichi","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_23","first-page":"a008714","article-title":"Mechanisms of action of Bcl-2 family proteins","volume":"5","author":"Kale","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/cdd.2017.186","article-title":"BCL-2 family proteins: Changing partners in the dance towards death","volume":"25","author":"Kale","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/febs.14186","article-title":"Bax, Bak and beyond\u2013mitochondrial performance in apoptosis","volume":"285","year":"2018","journal-title":"FEBS J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41467-022-28741-7","article-title":"Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer","volume":"13","author":"Lopez","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.cellsig.2008.04.015","article-title":"Regulation of pro-apoptotic BH3-only proteins and its contribution to cancer progression and chemoresistance","volume":"20","year":"2008","journal-title":"Cell Signal."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Blenk, S., Engelmann, J.C., Pinkert, S., Weniger, M., Schultz, J., Rosenwald, A., M\u00fcller-Hermelink, H.K., M\u00fcller, T., and Dandekar, T. (2008). Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-106"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1083\/jcb.201501101","article-title":"A little sugar goes a long way: The cell biology of O-GlcNAc","volume":"208","author":"Bond","year":"2015","journal-title":"J. Cell Biol."},{"key":"ref_30","first-page":"145","article-title":"O-GlcNAcylation and metabolic reprogramming in cancer","volume":"5","author":"Forma","year":"2014","journal-title":"Front. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/1535-7163.MCT-17-0390","article-title":"Inhibition of O-GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid","volume":"17","author":"Luanpitpong","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.bbadis.2018.09.010","article-title":"Reactive oxygen species mediate cancer stem-like cells and determine bortezomib sensitivity via Mcl-1 and Zeb-1 in mantle cell lymphoma","volume":"1864","author":"Luanpitpong","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-030-38266-7_6","article-title":"Resistance to the proteasome inhibitors: Lessons from multiple myeloma and mantle cell lymphoma","volume":"1233","author":"Quinet","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_34","first-page":"4585","article-title":"Nitric oxide and aggressive behavior of lung cancer cells","volume":"35","author":"Luanpitpong","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Medan, D., Luanpitpong, S., Azad, N., Wang, L., Jiang, B.H., Davis, M.E., Barnett, J.B., Guo, L., and Rojanasakul, Y. (2012). Multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of Cr(VI)-transformed lung cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037045"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2015.50","article-title":"The BCL-2 protein family, BH3-mimetics and cancer therapy","volume":"22","author":"Delbridge","year":"2015","journal-title":"Cell Death Differ."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.acr.2017.11.001","article-title":"Bcl-2 antiapoptotic family proteins and chemoresistance in cancer","volume":"137","author":"Maji","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41419-020-03144-y","article-title":"Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance","volume":"11","author":"Kapoor","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41375-022-01627-9","article-title":"Tipping the balance: Toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma","volume":"36","author":"Thus","year":"2022","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3389\/fonc.2018.00645","article-title":"BCL2-family dysregulation in B-cell malignancies: From gene expression regulation to a targeted therapy biomarker","volume":"8","author":"Tessoulin","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1046\/j.1365-2141.1996.423958.x","article-title":"Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas","volume":"92","author":"Xerri","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Morales-Mart\u00ednez, M., and Vega, M.I. (2022). Roles and regulation of BCL-xL in hematological malignancies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042193"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1074\/jbc.M109.038331","article-title":"The anti-apoptotic protein BCL2L1\/Bcl-xL is neutralized by pro-apoptotic PMAIP1\/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression","volume":"285","author":"Hagenbuchner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V86.5.1903.bloodjournal8651903","article-title":"Expression of bcl-xL can confer a multidrug resistance phenotype","volume":"86","author":"Minn","year":"1995","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41418-020-00692-w","article-title":"Regulation of Bcl-XL by non-canonical NF-\u03baB in the context of CD40-induced drug resistance in CLL","volume":"28","author":"Haselager","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/med.21379","article-title":"Direct activation of Bax protein for cancer therapy","volume":"36","author":"Liu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2014-03-560284","article-title":"Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma","volume":"123","author":"Fresquet","year":"2014","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1172\/JCI118684","article-title":"Balancing cell life and death: Bax, apoptosis, and breast cancer","volume":"97","author":"Reed","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bjh.14571","article-title":"Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma","volume":"177","author":"Montraveta","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","article-title":"BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis","volume":"8","author":"Cheng","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1038\/ncomms10538","article-title":"Mito-priming as a method to engineer Bcl-2 addiction","volume":"7","author":"Lopez","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/14474\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:22:58Z","timestamp":1760145778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/22\/14474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":52,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232214474"],"URL":"https:\/\/doi.org\/10.3390\/ijms232214474","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]}}}